Ricardo Valle-Diez

Madrid, MD 28040, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center Series.

Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center Series.

Journal: Vaccines

Published: December 10, 2025

Giant Intrabdominal Meningocele in a Patient with Marfan Syndrome: Case Description and Surgical Management.

Giant Intrabdominal Meningocele in a Patient with Marfan Syndrome: Case Description and Surgical Management.

Journal: Neurocirugia

Published: February 21, 2025

Brain metastasis treatment guidelines: consensus by the Spanish Society of Neurosurgery Tumor Section.

Brain metastasis treatment guidelines: consensus by the Spanish Society of Neurosurgery Tumor Section.

Journal: Neurocirugia

Published: April 11, 2023

Long-Term Outcomes in Resected IDH-Mutant Subtypes of Diffuse Low-Grade Glioma.

Long-Term Outcomes in Resected IDH-Mutant Subtypes of Diffuse Low-Grade Glioma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 28, 2023

Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.

Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.

Journal: The New England journal of medicine

Published: June 29, 2022

Low grade gliomas guide-lines elaborated by the tumor section of Spanish Society of Neurosurgery.

Low grade gliomas guide-lines elaborated by the tumor section of Spanish Society of Neurosurgery.

Journal: Neurocirugia

Published: March 09, 2022

Erratum: miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs.

Erratum: miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs.

Journal: Archives of clinical and biomedical research

Published: December 10, 2021

Ki-67 Proliferative Activity in the Tumor Margins as a Robust Prognosis Factor in Glioblastoma Patients.

Ki-67 Proliferative Activity in the Tumor Margins as a Robust Prognosis Factor in Glioblastoma Patients.

Journal: Journal of neurological surgery. Part A, Central European neurosurgery

Published: December 01, 2020

miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs.

miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs.

Journal: Archives of clinical and biomedical research

Published: September 09, 2020

RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases.

RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases.

Journal: Neuro-oncology advances

Published: July 10, 2020

Glioblastoma treatment guidelines: Consensus by the Spanish Society of Neurosurgery Tumor Section.

Glioblastoma treatment guidelines: Consensus by the Spanish Society of Neurosurgery Tumor Section.

Journal: Neurocirugia

Published: March 28, 2020

Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.

Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.

Journal: PloS one

Published: July 09, 2019

Showing 1-12 of 35

Last Updated: 09/26/2026